Prezcobix FDA Approval History
FDA Approved: Yes (First approved January 29, 2015)
Brand name: Prezcobix
Generic name: cobicistat and darunavir
Dosage form: Tablets
Company: Johnson & Johnson Innovative Medicine
Treatment for: HIV Infection
Prezcobix (darunavir and cobicistat) is a once-daily fixed-dose combination containing a protease inhibitor and a pharmacokinetic enhancer for the treatment of HIV-1 infection.
Development timeline for Prezcobix
| Date | Article |
|---|---|
| Jan 29, 2015 | Approval FDA Approves Prezcobix (darunavir and cobicistat) for HIV-1 Infection in Adults |
| Apr 1, 2014 | Janssen Submits NDA for a Fixed-Dose Combination of Darunavir with Cobicistat |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.